Objective: Effects of progressive substitution of dietary nÀ3 fatty acids (FA) for saturated FA (SAT) on modulating risk factors for atherosclerosis have not been fully defined. Our previous reports demonstrate that SAT increased, but nÀ3 FA decreased, arterial lipoprotein lipase (LpL) levels and arterial LDLcholesterol deposition early in atherogenesis. We now questioned whether incremental increases in dietary nÀ3 FA can counteract SAT-induced pro-atherogenic effects in atherosclerosis-prone LDL-receptor knockout (LDLRÀ/À) mice and have identified contributing mechanisms. Methods and results: Mice were fed chow or high-fat diets enriched in SAT, nÀ3, or a combination of both SAT and nÀ3 in ratios of 3:1 (S:nÀ3 3:1) or 1:1 (S:nÀ3 1:1). Each diet resulted in the expected changes in fatty acid composition in blood and aorta for each feeding group. SAT-fed mice became hyperlipidemic. By contrast, nÀ3 inclusion decreased plasma lipid levels, especially cholesterol. Arterial LpL and macrophage levels were increased over 2-fold in SAT-fed mice but these were decreased with incremental replacement with nÀ3 FA. nÀ3 FA partial inclusion markedly decreased expression of proinflammatory markers (CD68, IL-6, and VCAM-1) in aorta. SAT diets accelerated advanced atherosclerotic lesion development, whereas all nÀ3 FA-containing diets markedly slowed atherosclerotic progression. Conclusion: Mechanisms whereby dietary nÀ3 FA may improve adverse cardiovascular effects of high-SAT, high-fat diets include improving plasma lipid profiles, increasing amounts of nÀ3 FA in plasma and the arterial wall. Even low levels of replacement of SAT by nÀ3 FA effectively reduce arterial lipid deposition by decreasing aortic LpL, macrophages and pro-inflammatory markers.
Introduction
Many studies, including our own, have shown that dietary fatty acids (FA) affect pathways related to atherogenesis [1e3] . We have reported that dietary saturated FA (SAT) increased arterial lipoprotein lipase (LpL) levels, and that this was associated with increased arterial LDL deposition before the development of atherosclerotic lesions [1, 4, 5] . By contrast, nÀ3 FA-rich diets decreased arterial wall LDL deposition and LpL levels [4, 5] . nÀ3 FA in in vivo and in vitro model systems have been shown to decrease pro-inflammatory markers that can slow atherosclerosis [3e7] . Still, much of our information about the mechanisms underlying the role of dietary FA in atherogenesis is derived from laboratory studies using high-fat diets enriched in SAT, nÀ6 polyunsaturated FA, or nÀ3 FA only. In the United States, dietary fat intake usually includes SAT but with very low levels of nÀ3 FA [8, 9] . Replacement of SAT by nÀ6 polyunsaturated FA may decrease risk factors for cardiovascular disease (CVD) in part by decreasing blood levels of total cholesterol, LDL-cholesterol, triglycerides (TG) and inflammatory markers in humans [10] . Replacing SAT with nÀ3 may decrease the risk for CVD even more than nÀ6 alone [11] . Although controversy continues on the effects of nÀ3 supplementation on human CVD [12, 13] , little is known about the effects of progressively increasing dietary intake of nÀ3 FA on modulating arterial lipid deposition and atherosclerosis.
The pathogenesis of atherosclerosis has been studied in a number of animal species, such as monkeys, baboons, pigs, rabbits, hamsters, rats and mice. There are differences between species with respect to the influences of dietary nÀ3 FA on atherosclerosis [14] . C57BL/6 and insulin resistant mouse models that we have used to demonstrate the effects of dietary FA on regulating arterial LDL uptake and LpL levels have some limitations [4, 5] . For example, they do not develop atherosclerosis even on high-fat diets. The use of genetic knockout has created the mouse strains, such as apoE knockout (apoEÀ/À) and LDL-receptor knockout (LDLRÀ/À) mice, with altered lipoprotein profiles and susceptibility to atherosclerosis. However, none of the current mouse models develops the extensive lesions comparable to human atherosclerosis and acute cardiovascular events [15] . Compared to LDLRÀ/À mice, apoEÀ/À mice exhibit a higher inflammatory state [16, 17] , develop complex atherosclerotic lesion spontaneously [15] and respond poorly to nÀ3 FA intervention [18] . Thus, in the current studies, we evaluated the regulatory effects of dietary SAT being replaced with nÀ3 FA on the progression of atherosclerosis and arterial LpL levels and localization in a mouse model for diet-inducible atherosclerosis, LDLRÀ/À mice. LDLRÀ/À mice were fed custom-made diets varying only in lipid composition; a low-fat chow diet or high-fat, high-cholesterol diet enriched in either saturated fats, nÀ3 fats, or a combination of SAT and nÀ3 fats in ratios of 3:1 or 1:1 for 12 weeks. Our data demonstrate that increasing replacement of SAT by nÀ3 FA intake abrogated the adverse effects mediated by SAT. Underlying responsible mechanisms relate to a) improved mouse plasma lipid profiles and lowered total and LDL-cholesterol levels; b) reduced aortic macrophageassociated LpL; and c) decreased aortic macrophage markers and pro-inflammatory markers. The net result was a progressive decrease of atherosclerosis in LDLRÀ/À mice with increasing nÀ3 intake especially when compared with the SAT diet alone.
Materials and methods
Detailed methods are available as Supplemental materials.
Feeding protocols
Feeding studies were repeated twice and conducted over two different time periods (a total of 150 nine-week-old male LDLRÀ/À mice, The Jackson Laboratory). In each set of studies, 75 mice LDLRÀ/À mice were fed custom-made eucaloric diets (Harlan Teklad); a low-fat chow diet or high-fat, high-cholesterol diet enriched in either saturated fats (coconut oil), nÀ3 fats (menhaden oil), or a combination of SAT and nÀ3 fats in ratios of 3:1 (25% nÀ3) or 1:1 (50% nÀ3) for 12 weeks. The low-fat chow and high-fat diets contained 50 g fat and 0.2 g cholesterol, and 185 g fat and 2 g cholesterol per kg of diet, respectively. Supplemental Tables 1 and 2 list the detailed composition of macronutrients and measured fatty acid profile of each diet, respectively. Fasting mouse plasma was collected monthly and measured for levels of free FA (FFA) (NEFA C kit, Wako), TG, and total cholesterol (Chol) (Roche Diagnostics) according to the manufacturer's procedures as previously detailed [19] . The results from the two feeding studies were very similar. All experimental procedures were approved by the Columbia University Institutional Animal Care Committee.
Fatty acid composition of mouse feed and aorta
Lipid extracts from mouse plasma, artery and mouse feed from each feeding group were analyzed for FA composition by gaseliquid chromatography (GLC) as previously described [20, 21] . Results were normalized for weight percent of each FA.
Immunofluorescent studies
The localization of arterial LpL with aortic cells was examined by immunofluorescence (IFC) as described previously [5] . Sections of proximal aorta and aortic root were co-incubated with primary goat anti-LpL, rat anti-EC (CD31) and rabbit anti-macrophage (CD68) antibodies for 24 h at 4 C, followed by 1-h incubation of the mixture of corresponding fluorescent secondary. Fluorescence in the arterial wall was analyzed using a laser scanning confocal microscope (LSM-510 META). An argon laser (488 nm) and two helium-neon lasers (543 nm and 633 nm) were utilized for the excitation of Alexa 488, 546, and 647, respectively. Fluorescence of LpL and macrophages was quantitated as previously detailed [5, 22] .
Laser capture microdissection (LCM)
Macrophages from the aortic root were extracted by LCM for LpL expression as previously described [23] . Slides stained for macrophages were used to navigate and select macrophage-containing areas on the adjacent slides. Sequential slides with corresponding area of macrophages were stained with Harris modified hematoxylin and eosin and were used for microdissection using PALM MicroBeam IV (P.A.L.M. Microlaser Technologies). RNA extraction, amplification and analyses from collected aortic macrophages were performed following the manufacturer's instructions (MicroRNA Isolation kit, Stratagene, and MessageAmp II aRNA Amplification Kit, Ambion).
Quantitative real-time PCR
Total RNA was isolated from mouse proximal aorta with TRIzol reagent (Invitrogen). Single strand cDNA was synthesized using iScript reverse transcriptase (Invitrogen). Quantitative real-time PCR was carried out on an iCycler (Bio-Rad) using SYBR PCR kit (Applied Biosystems). Results were analyzed by comparing the threshold crossing (Ct) of each sample after normalization to control genes (DCt) using the formula 2 eDCt . Supplemental Table 3 lists the primer sequences.
Morphometric analyses of atherosclerosis
Atherosclerotic lesion development was measured at the aortic root. Sections of aortic valve were stained with Harris modified hematoxylin and Oil-Red-O (Fisher Scientific) [24] . Aortic lesion formation in each animal was measured as total lesion area (mm 2 ) per section from the point at which all three aortic valve leaflets first appeared according to the method by Paigen et al. [24] .
Statistical analyses
Student's t-tests of group means were used to compare endpoints, and ANOVA was used to evaluate potential interactions between diets. The results from two sets of feeding studies were combined by normalizing to the mean of each chow-fed group and are expressed as the mean fold change AESE. Statistical significance was determined at the level of p < 0.05.
Results

Body weight and plasma lipid levels
LDLRÀ/À mice were fed a regular rodent chow diet or diets enriched in only SAT, nÀ3 fats, or a combination of both SAT and nÀ3 fats in ratios of 3:1 (S:nÀ3 3:1) or 1:1 (S:nÀ3 1:1) for 12 weeks. All groups gained weight during the feeding period (supplemental Fig. 1 ): SAT and S:nÀ3 3:1 diet-fed mice had the highest increases, whereas chow-fed mice had the lowest increases in body weight (p < 0.05). The average daily intake among each feeding group was similar (data not shown).
Plasma lipid profiles were determined in LDLRÀ/À mice at the end of 12-week feeding period. SAT diets led to a w 40% increase in plasma FFA and a >50% increase in TG levels (p < 0.01, Fig. 1 , A and B) when compared with the chow diets. Inclusion of nÀ3 FA in S:nÀ3 3:1 and 1:1 diets substantially decreased FFA and TG even when compared with chow-fed mice (Fig. 1, A and B) . LDLRÀ/À mice (on chow diet) had elevated plasma cholesterol levels when compared with those previously described in C57BL/6 mice [4] , SAT-only feeding resulted in marked hypercholesterolemia in LDLRÀ/À mice. Mice fed the nÀ3-containing S:nÀ3 3:1 and 1:1 diets had much lower cholesterol levels than SAT-only fed-mice, comparable with chow-fed mice, while nÀ3-only diet-fed mice had the lowest plasma cholesterol levels (p < 0.01, Fig. 1C ). Note that the cholesterol content in each of these high-fat diets is considerable (0.2%, w/w) when compared with the chow diet (0.02%, w/w). Therefore, we suggest that nÀ3 FA are effective in reducing plasma lipid levels, including cholesterol levels, in LDLRÀ/À mice, even when on high-cholesterol, high-fat diets.
Effects of dietary FA on plasma and aortic fatty acid composition
Effects of dietary FA intake on fatty acid composition were evaluated in circulating plasma and in aorta using GLC in LDLRÀ/À mice after each feeding period. As shown in Table 1 , nÀ6 FA-rich chow diet, which contained >50% of its FA as linoleic acid (LA, 18:2) (supplemental Table 2 ), proportionally raised LA levels in mouse plasma. Despite the fact that all high-fat diets contained w8% of LA, LA was decreased in both plasma and aorta in mice fed S:nÀ3 1:1 and nÀ3-only diets (Table 1) . Although nÀ6 arachidonic acid (AA, 20:4) was not detected in the SAT diets, a significant amount of AA was present in both plasma and aorta in SAT-fed mice. SAT also increased saturated lauric acid (12:0) and myristic acid (14:0) in plasma and aorta (p < 0.05). Mouse plasma and aortic a-linolenic acid (ALA 18:3) content was not affected by feeding the diets with different levels of ALA. On the other hand, progressive addition of nÀ3 fats in diets markedly and progressively increased arterial nÀ3 eicosapentaenoic acid (EPA, 20:5) and docosahexaenoic acid (DHA, 22:6) in mouse plasma (p < 0.05) and artery (p < 0.05), whereas saturated lauric and myristic acid were progressively decreased. DHA in the aorta increased much more than EPA in nÀ3-fed mice, although nÀ3 diets contained higher amounts of EPA when compared to DHA. Overall, each diet resulted in the expected changes in fatty acid composition in blood and aorta for each feeding group (supplemental Table 2 ).
Aortic LpL, macrophages and inflammatory mediators in LDLRÀ/À mice
As described in our previous studies [4, 5] , SAT diets increased, but nÀ3 diets decreased, LpL in the proximal aorta in wild-type C57BL/6 mice and insulin resistant mice; increases in arterial LpL levels were linked to aortic macrophage number [4, 5] . In the current studies, while using endothelial cell (EC) staining for orientation of aorta sections and as a positive control, immunofluorescent images showed that SAT diets increased, whereas nÀ3 decreased, arterial LpL and macrophages in the proximal aorta (Fig. 2, A and B, p < 0.05). Although LpL increased, non-significantly, in the proximal aorta of mice fed the high-fat, high-cholesterol S:nÀ3 3:1 and 1:1 diets when compared with chow-fed mice, all high-fat diets containing nÀ3 FA markedly reduced aortic macrophages when compared with the SAT diet, and in fact were comparable with the low-fat, low-cholesterol chow diet (Fig. 2B) . Quantitative immunofluorescence of EC did not change with changes in dietary FA content (data not shown). In aorta, we compared how different SAT and nÀ3 FA-rich diets regulate gene expression of selected markers that are involved in the inflammatory responses. SAT diets also significantly increased macrophage CD68 and pro-inflammatory interleukin-6 (IL-6), vascular cell adhesion molecule-1 (VCAM-1) and Toll-like receptor-4 (TLR-4) several fold higher than in the chow-fed group (Fig. 2C , p < 0.05). In contrast to SAT, diets containing nÀ3 FA, even the S:nÀ3 3:1 diets in which the nÀ3 FA diet comprised as little as 25% fish oil of the total fat content, led to substantially decreased gene expression of those pro-inflammatory markers (p < 0.05). Expression of TLR-4 downstream signaling factor (NF-lB) and its target gene (TNF-a) was also decreased by nÀ3 diets (data not shown). A tendency for mild increases in mRNA gene expression of antiinflammatory IL-10 was found in the nÀ3 fed group (data not shown). Note that decreased expression of pro-inflammatory markers in aorta after feeding with nÀ3-containing diets was consistent with decreases in plasma pro-inflammatory molecules: all high-fat, nÀ3-containing diets reduced plasma monocyte chemotactic protein-1 (MCP-1) and IL-6 levels in LDLRÀ/À mice by more than 30% and 50%, respectively, when compared with chowor SAT-fed mice (data not shown).
Next, we examined LpL and macrophages in atherosclerotic lesions at the aortic origin (Fig. 3) , where the atherosclerotic lesions usually initially develop in mouse models. Most LpL that was present in atherosclerotic lesions colocalized with macrophages among each feeding group (Fig. 3A) . Fluorescent staining of LpL and macrophages increased with an increase in lesion area and severity of atherosclerosis. SAT-fed mice with the extensive lesions had the highest numbers of macrophages as well as higher levels of LpL in the aortic root compared with mice fed the nÀ3 diets that showed lower levels of fluorescence for LpL and macrophages.
Macrophages from the atherosclerotic lesions at aortic root in LDLRÀ/À mice were extracted by laser capture microdissection (LCM) and then were pooled for gene amplification for each group. Gene expression analyses show that LpL levels were indeed increased in aortic macrophages from SAT-fed mice, while nÀ3 markedly decreased LpL mRNA (Fig. 3B) . Binding of peroxisome proliferator-activated receptors (PPAR) to the peroxisome proliferator response element (PPRE) consensus sequence on LpL promoter is shown to induce LpL gene expression. We sought to examine the expression of three isoforms of PPARs, PPARa, PPARg and PPARb/d, in isolated macrophages by LCM (Fig. 3, CeE) . The data show that expression of PPARa and PPARg tended to increase in SAT-and nÀ3-fed compared to chow-fed mice, whereas expression of PPARb/d increased by SAT but decreased by nÀ3 diets (Fig. 3D and E) . Changes in expression of PPARb/d mediated by dietary FA may link to macrophage-LpL expression in macrophages.
Dietary nÀ3 FA reduce atherosclerosis in SAT-fed mice
We examined the effects of incremental increases in nÀ3 FA on the progression of atherosclerotic lesions in LDLRÀ/À mice after 12 weeks of feeding (Fig. 4) . In chow-fed LDLRÀ/À mice, modest fatty streaks developed in the sections of the aortic valve (Fig. 4A) . Advanced complex plaques with substantial lipid deposition were observed in all SAT-fed mice as indicated by staining of hematoxylin and Oil-Red-O. Diets that contained 25% nÀ3 fats (S:nÀ3 3:1) or 50% (S:nÀ3 1:1) on a background of high-SAT effectively inhibited atherosclerotic lesion development in LDLRÀ/À mice. Mice fed the high-fat, high-cholesterol S:nÀ3 3:1 diet had reduced lesion development comparable to low-fat, low-cholesterol chow-fed mice. There were no or only small fatty streaks found in nÀ3-only-fed mice (Fig. 4A) .
The extent of the atherosclerosis was quantitated for each feeding group (Fig. 4B) . Mean lesion area mass was 16.88 AE 0.10 mm 2 Table 1 Plasma and aortic fatty acid composition in LDLRÀ/À mice (weight % of total fatty acids). (w 5% per total aortic area) in chow-fed LDLRÀ/À mice. Atherosclerotic lesion size was significantly increased in SAT-fed LDLRÀ/À mice (p < 0.01). LDLRÀ/À mice fed the nÀ3-only diets had the lowest levels of atherosclerotic lesion formation (p < 0.01, Fig. 4B ). Mice fed the S:nÀ3 3:1 or 1:1 diet had much less of an increase in lesion size, comparable with chow-fed mice.
Discussion
Dietary FA play an important role in influencing pathways of atherogenesis at an early stage, where arterial LDL and LDLcholesterol deposition contributes to the initiation of atherosclerotic lesion formation [4, 5] . Effects of progressive substitution of dietary nÀ3 FA for SAT on modulating risk factors for atherosclerosis are not fully understood. In the studies described here, on a background of high-SAT and high-cholesterol intakes, we explored the effects of incremental increases of dietary nÀ3 FA on atherogenic markers and on the extent and severity of atherosclerosis in LDLRÀ/À mice. As expected, when LDLRÀ/À mice were fed the high-SAT diets, their plasma FFA and TG levels were markedly elevated. They were also hypercholesterolemic and developed advanced atherosclerosis. Progressive replacement of SAT with nÀ3 markedly inhibited pro-atherogenic contributors to atherosclerosis including elevated plasma lipids, plasma and aortic proinflammatory markers, aortic LpL and macrophages, resulting in decreased atherosclerotic lesion development. Our data indicate that high levels of saturated FA alter recruitment of different cell populations to the arterial wall, particularly accumulation of macrophages that secrete LpL, and thus favor the development of atherosclerosis. Increased arterial LpL in SAT-fed LDLRÀ/À mice might be associated with increasing arterial lesions by mediating uptake, binding, and retention of LDL in aorta [1] , a key step in initiating atherosclerosis. Increased arterial LpL might also lead to increased local TG hydrolysis to supply extra energy for aortic cells (i.e., metabolically active macrophages in the arterial wall) resulting in accelerated atherosclerotic lesion formation. Tissue-specific expression of LpL contributes to differences in the role of LpL in mediating atherosclerosis. For example, systemic overexpression of LpL suppressed diet-induced atherosclerosis in LDLRÀ/À mice [25] and apoEÀ/À mice [26] . By contrast, heterozygous LpL deficiency diminished the retention of atherogenic lipoproteins in LDLRÀ/À [27] . Also, macrophage overexpressing LpL into LDLRÀ/À mice markedly increased atherosclerosis [28] . The latter two studies are in agreement with our findings that dietary nÀ3 FA intake reduces arterial LpL levels, which in turn leads to reduced atherosclerosis. We postulate that increased LpL in response to SAT was locally produced by arterial cells-macrophages and, possibly smooth muscle cells (SMC). However, in our previous studies, we did not find significant changes in SMC-LpL mediated by dietary FA in C57BL/6 mice by immunofluorescence; SMC accounted for only small amounts of arterial wall LpL protein (Chang, Deckelbaum, unpublished data) . Note that in nÀ3-fed LDLRÀ/À mice, LpL mRNA was decreased in isolated aortic macrophages extracted by LCM (Fig. 3) . Therefore, we suggest that dietary FA influence arterial LpL transcription and expression in a cell-specific manner and that these changes in arterial wall LpL are largely associated with modulation of aortic macrophage-LpL. Decreased number of arterial macrophages with the apparent decrease in macrophage-LpL expression is, we suggest, an important mechanism underlying the reduced levels of aortic LpL mediated by nÀ3 feeding. Decreased numbers of arterial macrophages after nÀ3 feeding likely link to anti-inflammatory pathways associated with nÀ3 FA [29] . Other mechanisms underlying the differential regulation of dietary FA on inflammatory responses could include the alteration of monocyte trafficking and macrophage retention in the arterial wall. It has been shown that nÀ3 FA reduced inflammatory Ly6C hi monocytes and monocyte infiltration that decreased atherosclerosis in LDLRÀ/À mice [30] . There is considerable evidence suggesting roles for PPARs in mediating multiple biological events related to atherosclerosis. FA and their derivatives (e.g., eicosanoids) are endogenous ligands for PPARs [31] . The interaction of LpL and PPARs has been examined elsewhere [32, 33] , and indicates that different PPARs can affect LpL levels. In addition, incubation of macrophages with PPAR agonists has been shown to affect inflammatory gene expression [33e35], which could also contribute to changes in arterial LpL levels and activity. Our findings show PPARa and PPARg expression levels were increased by both SAT and nÀ3 FA, whereas PPARb/d was increased by SAT, but decreased by nÀ3 diets. We speculate that PPARb/d may have a role in mediating FA-induced atherogenic effects by regulating LpL expression involved in arterial lipid deposition and inflammatory responses. While sample size was small in examining macrophage-specific LpL and PPARs by LCM, the data points towards underlying mechanisms that may contribute to an understanding of effects mediated by nÀ3 vs. SAT diets.
Low or moderate intake of nÀ3 FA (250e500 mg/day) may decrease risk for CVD events [36, 37] . In these studies, progressive addition of nÀ3 fats in diets progressively increased nÀ3 EPA, docosapentaenoic acid (DPA) and DHA in artery (Table 1) . We postulate that changes in aortic fatty acid composition can affect a number of pathways related to atherogenesis. It has been reported that nÀ3 incorporation into cell membrane phospholipids modulated membrane fluidity by altering the properties of lipid rafts and caveolae, leading to modulation of membrane-associated proteins and receptor activities [38] . Membrane incorporation of nÀ3 FA decreased the generation of intracellular reactive oxygen species with a subsequent diminished activation of redox-sensitive transcription factors, such as nuclear factor-kB (NF-kB) [39] . nÀ3 FA signaling through a G-protein coupled receptor, GPR120, is reported to modulate inflammation and insulin-sensitizing effects in monocytes and macrophages [40] .
Increased polyunsaturated nÀ6 FA intake is associated with reduced risk of CVD [41] . However, concerns have been raised regarding high nÀ6 intake may accelerate the conversion of nÀ6 18: 2 LA into 20:4 AA, which is a major substrate of proinflammatory eicosanoids and cytokines. Although there are inconsistent findings of protective effects of nÀ3 FA on atherogenesis in animal models [30, 42] , lower ratios of nÀ6/nÀ3 FA intakes are still favorable toward reducing atherosclerosis [43, 44] . Might our results be related to the effects of the different diets on nÀ6 FA intake? We suggest this is not the case for the following reasons. In our studies, all high-fat diets utilized in our feeding studies contained nÀ6 LA at much lower but equivalent levels (w8% LA in total FA, supplemental Table 2 ) when compared with the chow diet (50% LA). However, increasing nÀ3 fish oil intake decreased LA levels in mouse plasma and artery when compared with SAT (Table 1) . In fact, all diets containing nÀ3 FA reduced plasma lipids and significantly reduced atherosclerosis even when compared with the SAT or nÀ6-rich chow diet. Therefore, we suggest that it is nÀ3 FA, rather than nÀ6 FA, that accounted for improving plasma lipid profiles and slowing atherosclerosis.
In our previous studies, we have showed that dietary intake of nÀ3 FA inhibited factors that initiate atherosclerosis such as elevated cholesterol levels and arterial LDL deposition, even before the appearance of the atherosclerotic lesions [4, 5] . Our current studies carried out in an atherosclerosis-prone mouse model demonstrate directly that, even in the setting of a high-total fat, high-cholesterol, SAT-enriched diet, nÀ3 FA were effective in reducing atherosclerotic lesion formation. We suggest a number of mechanisms underlying protection from arterial lipid deposition and atherosclerosis by dietary nÀ3 FA. These include effects on ameliorating adverse plasma lipid profiles and reducing aortic macrophages, macrophage-associated LpL and pro-inflammatory markers. While some controversy continues in the recent literature showing inconsistent effects of nÀ3 FA on reducing CVD mortality after a cardiac event [12, 13] . Potential reasons for different results in human nÀ3 trials have been reviewed elsewhere [13, 45, 46] . Still, many mechanistic studies indicate beneficial effects of nÀ3 FA in preventing adverse outcomes in the pathogenesis of CVD. We now provide additional evidence and describe underlying pathways that highlight the role of nÀ3 FA as part of strategic approaches to decrease risks for CVD in humans. 
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